Apogenix and R-Biopharm Partner to Advance Diagnostics for APG101
News
Specialized immuno-oncology company, Apogenix, recently announced a new agreement with R-Biopharm, a multinational provider of novel clinical diagnostics, to create complementary tests for Apogenix’ flagship pipeline product, APG101 – a ... Read more